Market Sentiment Around Loss-Making Akebia Therapeutics, Inc. (NASDAQ:AKBA)
Akebia Stock Climbs 8% on Dialysis Provider Supply Agreement
Akebia Therapeutics Signs A Multi-Year Commercial Contract With One Of The Nation's Leading Providers Of Kidney Care Services, Expanding Access To Vafseo For Patients On Dialysis; The Contract Enables Physicians To Prescribe Vafseo To Patients On...
Express News | Akebia Therapeutics Inc - Vafseo Expected to Be Available in U.S. in January 2025
Express News | Akebia Therapeutics Signs Commercial Supply Contract With Leading Dialysis Organization to Enable Access to Vafseo® (Vadadustat) for Patients on Dialysis
Express News | Akebia Therapeutics Inc: Co & Sta Entered Into Amendment Ž1 to Supply Agreement